Fig. 11From: Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancerSensitivity of chemotherapy drug. a-i Difference in the estimated IC50 levels of Cisplatin (a), Bleomycin (b), Docetaxel (c), Gemcitabine (d), Vinblastine (e), Vinorelbine (f), Paclitaxel (g), Rucaparib (h) and Veliparib (i). Data are shown as means ± S.D. ns not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001Back to article page